Results · Apr-Jun 2026
Dr. Lal Pathlabs Q1 FY27 results
Very strongVery strong: sales up 15% or more & profit up 25% or more on the same quarter last year, with a wider operating margin.
Sales grew 19% to ₹798 crore from ₹670 crore in Apr-Jun 2025.
Operating profit grew 29% to ₹248 crore, an operating margin of 31.0% (up 2.3 points from a year ago).
Net profit grew 27% to ₹171 crore from ₹134 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +14%, net profit +29%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 797.7 | 669.8 | +19% |
| Operating profit (EBITDA) | 247.5 | 192.3 | +29% |
| Operating margin | 31.0% | 28.7% | +2.3 pts |
| Net profit | 170.5 | 134.0 | +27% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.